PRAGUE ? The evidence that led the FDA to warn that Paxil (paroxetine) taken during the first weeks of pregnancy increases the risk of birth defects, including serious heart defects, was disputed by German researchers today.
PRAGUE, June 19 ? The evidence that led the FDA to warn that Paxil (paroxetine) taken during the first weeks of pregnancy increases the risk of birth defects, including serious heart defects, was disputed by German researchers today.
In a German study women who used Paxil were, however, more likely to undergo abortion than women who didn't use an antidepressant during pregnancy (P
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.